A Pill to Treat Covid-19? The U.S. Is Betting on It. June 18, 2021 Auto Bot Clinical Trials, Coronavirus (2019-nCoV), Health and Human Services Department, Merck & Company Inc, National Institute of Allergy and Infectious Diseases, Remdesivir (Drug), Research, United States Politics and Government, your-feed-healthcare 0 A new $3.2 billion program will support the development of antiviral pills, which could start arriving by the end of this year.